Search Results - "Brittenham, G."

Refine Results
  1. 1

    Hepatic Iron Concentration and Total Body Iron Stores in Thalassemia Major by Angelucci, Emanuele, Brittenham, Gary M, McLaren, Christine E, Ripalti, Marta, Baronciani, Donatella, Giardini, Claudio, Galimberti, Maria, Polchi, Paola, Lucarelli, Guido

    Published in The New England journal of medicine (03-08-2000)
    “…Quantitative studies of iron balance in patients with thalassemia major have been limited by the lack of a method for determining the total amount of stored…”
    Get full text
    Journal Article
  2. 2

    Delayed hemolytic transfusion reaction in the French hemovigilance system by Rieux, C., Brittenham, G., Bachir, D., De Meyer, E., Boudjedir, K.

    “…In France, reporting of adverse events related, or likely to be related, to transfusion is mandatory. Since its creation in 1993, the French hemovigilance…”
    Get full text
    Journal Article
  3. 3

    Iron-chelating therapy and the treatment of thalassemia by OLIVIERI, N. F, BRITTENHAM, G. M

    Published in Blood (01-02-1997)
    “…Iron-chelating therapy with deferoxamine in patients with thalassemia major has dramatically altered the prognosis of this previously fatal disease. The…”
    Get full text
    Journal Article
  4. 4

    Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major by Olivieri, Nancy F, Brittenham, Gary M, McLaren, Christine E, Templeton, Douglas M, Cameron, Ross G, McClelland, Robert A, Burt, Alastair D, Fleming, Kenneth A

    Published in The New England journal of medicine (13-08-1998)
    “…Transfusions and iron-chelation therapy have dramatically improved the lives of patients with thalassemia major. 1 Transfusions can prevent death and promote…”
    Get full text
    Journal Article
  5. 5

    Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia Major by Brittenham, Gary M, Griffith, Patricia M, Nienhuis, Arthur W, McLaren, Christine E, Young, Neal S, Tucker, Eben E, Allen, Christopher J, Farrell, David E, Harris, John W

    Published in The New England journal of medicine (01-09-1994)
    “…An adequate transfusion program for patients with thalassemia major can prevent death from anemia in infancy and permit normal growth and development during…”
    Get full text
    Journal Article
  6. 6

    Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia Major by Olivieri, Nancy F, Brittenham, Gary M, Matsui, Doreen, Berkovitch, Matitiahu, Blendis, Laurence M, Cameron, Ross G, McClelland, Robert A, Liu, Peter P, Templeton, Douglas M, Koren, Gideon

    Published in The New England journal of medicine (06-04-1995)
    “…In patients with thalassemia major, a regular program of transfusion sustains growth and development during childhood, but without concomitant chelation…”
    Get full text
    Journal Article
  7. 7

    Iron balance in the red blood cell donor by Brittenham, G M

    Published in Developments in biologicals (2005)
    “…Phlebotomy of a unit of blood produces a loss of 200 to 250 mg of iron in haemoglobin. Because of physiological differences in iron balance between women of…”
    Get more information
    Journal Article
  8. 8

    Genetic Disorders Affecting Proteins of Iron Metabolism: Clinical Implications by Sheth, Sujit, Brittenham, Gary M

    Published in Annual review of medicine (01-01-2000)
    “…Remarkable progress is being made in understanding the molecular basis of disorders of human iron metabolism. Recent work has uncovered unanticipated…”
    Get full text
    Journal Article
  9. 9

    Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes: Implications for the arrhythmogenesis of human siderotic heart disease by KURYSHEV, Y. A, BRITTENHAM, G. M, FUJIOKA, H, KANNAN, P, SHIEH, C.-C, COHEN, S. A, BROWN, A. M

    Published in Circulation (New York, N.Y.) (10-08-1999)
    “…Patients with chronic iron overload may develop a cardiomyopathy manifested by ventricular arrhythmias and heart failure. We hypothesized that iron-loaded…”
    Get full text
    Journal Article
  10. 10

    Magnetic Measurement of Liver Iron Stores: Engineering Aspects of a New Scanning Susceptometer Based on High-Temperature Superconductivity by Farrell, D.E., Allen, C.J., Whilden, M.W., Tripp, J.H., Usoskin, A., Sheth, S., Brittenham, G.M.

    Published in IEEE transactions on magnetics (01-11-2007)
    “…We describe a new approach to the magnetic measurement of liver iron stores, using an instrument that incorporates a combination of permanent magnets and…”
    Get full text
    Journal Article
  11. 11

    Influence of Hemoglobin E Trait on the Severity of Falciparum Malaria by Hutagalung, Robert, Wilairatana, Polrat, Looareesuwan, Sornchai, Brittenham, Gary M., Aikawa, Masamichi, Gordeuk, Victor R.

    Published in The Journal of infectious diseases (01-01-1999)
    “…To determine if hemoglobin E trait influences the course of acute malaria, adults hospitalized for the treatment of symptomatic infection with Plasmodium…”
    Get full text
    Journal Article
  12. 12

    A New Instrument Designed to Measure the Magnetic Susceptibility of Human Liver Tissue In Vivo by Farrell, D.E., Allen, C.J., Whilden, M.W., Kidane, T.K., Baig, T.N., Tripp, J.H., Brown, R.W., Sheth, S., Brittenham, G.M.

    Published in IEEE transactions on magnetics (01-09-2007)
    “…All existing superconducting instrumentation for measuring the concentration of iron stored in the human liver requires liquid helium for its operation. We…”
    Get full text
    Journal Article
  13. 13

    Experimental liver cirrhosis induced by alcohol and iron by Tsukamoto, H, Horne, W, Kamimura, S, Niemelä, O, Parkkila, S, Ylä-Herttuala, S, Brittenham, G M

    Published in The Journal of clinical investigation (01-07-1995)
    “…To determine if alcoholic liver fibrogenesis is exacerbated by dietary iron supplementation, carbonyl iron (0.25% wt/vol) was intragastrically infused with or…”
    Get full text
    Journal Article
  14. 14

    HBED : A potential alternative to deferoxamine for iron-chelating therapy by BERGERON, R. J, WIEGAND, J, BRITTENHAM, G. M

    Published in Blood (15-02-1998)
    “…To examine the potential clinical usefulness of the hexadentate phenolic aminocarboxylate iron chelator N, N-bis(2-hydroxybenzyl)ethylenediamine-N,N-diacetic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Effects of C-4 Stereochemistry and C-4‘ Hydroxylation on the Iron Clearing Efficiency and Toxicity of Desferrithiocin Analogues by Bergeron, Raymond J, Wiegand, Jan, McManis, James S, McCosar, Bruce H, Weimar, William R, Brittenham, Gary M, Smith, Richard E

    Published in Journal of medicinal chemistry (01-07-1999)
    “…Additional structure−activity studies of desferrithiocin analogues are carried out. The effects of stereochemistry at C-4 on the ligands' iron clearing…”
    Get full text
    Journal Article
  18. 18
  19. 19

    New advances in iron metabolism, iron deficiency, and iron overload by Brittenham, G M

    Published in Current opinion in hematology (01-03-1994)
    “…Rapid advances were made in understanding the molecular and cellular bases of iron metabolism and its disorders. Molecular mechanisms for the cellular uptake,…”
    Get more information
    Journal Article
  20. 20

    Iron chelators and iron toxicity by Brittenham, Gary M.

    Published in Alcohol (Fayetteville, N.Y.) (01-06-2003)
    “…Iron chelation may offer new approaches to the treatment and prevention of alcoholic liver disease. With chronic excess, either iron or alcohol alone may…”
    Get full text
    Journal Article Conference Proceeding